| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 147.883 | 133.749 | 118.968 | 123.696 | 129.653 | 159.959 | 159.011 | 166.450 | 159.832 | 158.119 |
| Total Income - EUR | 148.390 | 136.504 | 119.127 | 124.078 | 129.943 | 160.047 | 162.046 | 169.820 | 160.352 | 158.171 |
| Total Expenses - EUR | 139.482 | 128.876 | 111.993 | 118.951 | 125.094 | 147.648 | 152.142 | 160.637 | 149.967 | 154.544 |
| Gross Profit/Loss - EUR | 8.908 | 7.628 | 7.134 | 5.127 | 4.849 | 12.399 | 9.904 | 9.183 | 10.385 | 3.627 |
| Net Profit/Loss - EUR | 7.667 | 6.590 | 5.959 | 3.890 | 3.574 | 11.042 | 8.369 | 7.782 | 8.813 | 3.082 |
| Employees | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Farmacia Annylon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 43.757 | 32.148 | 38.340 | 39.318 | 40.521 | 54.726 | 46.830 | 55.123 | 52.403 | 48.128 |
| Inventories | 13.633 | 19.431 | 21.865 | 19.323 | 21.567 | 29.196 | 23.930 | 30.872 | 32.327 | 31.217 |
| Receivables | 28.937 | 11.231 | 15.874 | 19.567 | 18.420 | 23.793 | 22.189 | 24.088 | 19.984 | 16.533 |
| Cash | 1.188 | 1.485 | 602 | 428 | 534 | 1.737 | 710 | 163 | 91 | 378 |
| Shareholders Funds | 7.924 | 6.844 | 6.209 | 4.135 | 3.808 | 11.271 | 8.593 | 8.006 | 9.037 | 3.304 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.833 | 25.303 | 32.613 | 35.727 | 37.352 | 44.082 | 38.705 | 47.117 | 43.366 | 44.824 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5231 - 5231" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Annylon Srl